Riskpilot← Back to searchSign inGet full accessGitte Gunnars AB
ABDissolvedOrg 5592274301FalunRetail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
497900.0%
+53% vs 2023
Equity ratio
67.6%
Financial strength
Net profit 2024
SEK -4K
+54% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -5K | +53% |
| Net profit | SEK -4K | +54% |
| Total assets | SEK 121K | -18% |
| Equity | SEK 82K | -5% |
| Employees | 0 | — |
Legal name
Gitte Gunnars AB
Org number
5592274301
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
19 november 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bemanning av farmacevttjänst
Address
Falun
Email
forelaggande-bv2@standardbolag.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 867 | 109 | 167 | 8 | −0 |
| Staff expenses | — | — | −171 | −13 | −0 |
| EBITDA | 210 | −104 | −25 | −10 | −5 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 210 | −104 | −25 | −10 | −5 |
| Net financials | — | −2 | 0 | 1 | 1 |
| Profit before tax | 160 | −56 | −25 | −9 | −4 |
| Tax | −34 | −0 | — | — | — |
| Net profit | 126 | −56 | −25 | −9 | −4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 519 | 194 | 198 | 148 | 121 |
| Equity | 176 | 120 | 95 | 86 | 82 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 294 | 74 | 102 | 62 | 39 |
| Total debt | 294 | 74 | 102 | 62 | 39 |
EBITDA margin
-497900.0%
This company
15.8%
Market median
-3151366% vs market
20202024
Equity ratio
67.6%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
-5.3%
This company
18.4%
Market median
-129% vs market
20202024
Net profit margin
-434400.0%
This company
8.1%
Market median
-5363063% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gitte Gunnars AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Birgitte Gunnars | Board of Directors | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Anna Elisabet Viktoria Björk | Deputy Board Member | 0 companies |
| Lars Olov Ohlsson | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Deputy Board Member | 0 companies |